FDA recall record

Unistrip Technologies UniStrip1, Blood Glucose Test Strips, 50 count box recall — FDA Z-0855-2015

Failure to submit a 510(k) for device labeling changes.

Class IIclassification
Z-0855-2015official record ID
Dec 31, 2014report date

Recall record at a glance

Official recordZ-0855-2015
CategoryMedical Device Recalls
ClassificationClass II
FDA record statusTerminated
Recalling firmUnistrip Technologies LLC
Report dateDec 31, 2014
Recall initiation dateNov 20, 2014
Quantity7175 units
LocationCharlotte, NC, United States

Official product description

UniStrip1, Blood Glucose Test Strips, 50 count box. The test strips are indicated for use by people with diabetes in their home as an aid to monitor the effectiveness of diabetes control.

Why the product was recalled

Failure to submit a 510(k) for device labeling changes.

Distribution information

US Distribution to the states of FL and OH.

How to read the classification

FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.